Navigation Links
Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
Date:6/22/2011

QUEBEC CITY, June 22, 2011 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll will be presenting at the 2011 BIO Business Forum during the annual BIO International Convention.  Mr. Driscoll's presentation will be given in the Georgetown Room of the Walter E. Washington Convention Center in Washington, DC on Wednesday, June 29, 2011 at 2:15 p.m. EDT.  The presentation will include an overview of the company's nictonic acetylcholine receptor technology, with emphasis on the lead development program for the treatment of asthma, ASM-024.

About Asmacure Ltee

Asmacure Ltee is a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases.  The company's lead compound, ASM-024, is a novel molecular entity currently in clinical development for the treatment of asthma.  ASM-024 utilizes Asmacure's proprietary technology comprised of nicotinic acetylcholine receptor agonists and is the first nicotinic receptor agonist in the clinic for this indication.  Phase II proof-of-concept studies are ongoing to assess the anti-inflammatory, bronchodilating and bronchoprotective properties of ASM-024 administered by inhalation.  

Asmacure is a privately held company located in Quebec City, Canada.  The major investors in Asmacure include Domain Associates, Fonds Bio-Innovation and Innovatech Quebec.  For more information visit www.asmacure.com

Media Contacts:
Tiberend Strategic Advisors, Inc.
(212) 827-0020
Andrew Mielach, amielach@tiberend.com
or
Claire Sojda, csojda@tiberend.com  


'/>"/>
SOURCE Asmacure Ltee
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ambrx to Present Data from Antibody Drug Conjugate Program at Upcoming Scientific Conferences
2. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
3. Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference
4. Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference
5. Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
6. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
7. Simulated Environment Concepts to Present at National Eagles and Angels Association New York Meeting
8. Radiation Therapy Services Holdings, Inc. to Present at the Wells Fargo Securities 2011 Healthcare Conference
9. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
10. ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011
11. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  Avista Pharma Solutions ("Avista Pharma") announced today ... Financial Officer (CFO). Mr. Setzer is a finance and ... various roles within growing technology and life science companies. ... Executive Director of Finance at INC Research, a publicly ... . Previously, Mr. Setzer served as CFO of ...
(Date:2/8/2016)... Velano Vascular, a medical technology company transforming ... their practitioners, announced today that the company has raised ... the proceeds from this financing, an extension of a ... to support the development and commercialization of the company,s ... Philadelphia , and a number ...
(Date:2/8/2016)... Fla. , Feb. 8, 2016 Vestagen ... marketing high performance apparel for healthcare and other demanding ... Chief Executive Officer. He replaces Dale Pfost ... remains Chairman. Mr. Bold is also joining Vestagen,s Board ... a new class of active barrier technologies that combines ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance ... beginning of a new charity campaign. As part of their ongoing community involvement ... In the belief that children deserve a voice, and in the spirit of ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that your ... are not alone. According to the Center for Disease Control and Prevention (CDC), 34.9% ... diabetes and certain types of cancer, some of the leading causes of preventable death. ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... excited to share this important news! AHCC and the Home Health and Hospice ... Clinic, CMS' designee for official ICD coding guidance and clarifications, to address concerns ...
Breaking Medicine News(10 mins):